N-Acetylcysteine in Patients With Sickle Cell Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Sickle Cell Disease
Interventions
DRUG

N-Acetylcysteine

DRUG

Placebo

Trial Locations (11)

Unknown

CHU Brugmann, Brussels

CHU St. Pierre, Brussels

Hôpital Erasme, Brussels

Hôpital Universitaire Des Enfants Reine Fabiola (HUDERF), Brussels

UCL St. Luc, Brussels

CHR de la Citadelle, Liège

Guys' & St. Thomas Hospital, London

1105 AZ

Academic Medical Center, Amsterdam

9713 GZ

University Medical Center Groningen, Groningen

3015 AA

Erasmus Medical Center, Rotterdam

2545 CH

Haga Hospital, The Hague

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

collaborator

Haga Hospital

OTHER

collaborator

University Medical Center Groningen

OTHER

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

collaborator

Fonds NutsOhra

OTHER

collaborator

Stichting Janivo

UNKNOWN

collaborator

CHU Brugmann, Brussels

OTHER

collaborator

Erasme University Hospital

OTHER

collaborator

Centre Hospitalier Régional de la Citadelle

OTHER

collaborator

University Hospital St Luc, Brussels

OTHER

collaborator

Centre Hospitalier Universitaire Saint Pierre

OTHER

collaborator

Queen Fabiola Children's University Hospital

OTHER

collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER